Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    supriya kashyap kashyap
    supriya kashyap kashyap
      • Home
      • supriya kashyap...

      Articles By : supriya kashyap kashyap

      Aster DM Healthcare to take $295 mln loan with Axis Bank

      Aster DM Healthcare to take $295 mln loan with Axis Bank

      supriya kashyap kashyap14 April 2017 11:19 AM IST
      United Arab Emirates-based Aster DM Healthcare has agreed a $295 million credit facility with India's Axis Bank, the healthcare company said in a...
      Bristol-Myers to license two drugs to Biogen, Roche

      Bristol-Myers to license two drugs to Biogen, Roche

      supriya kashyap kashyap14 April 2017 9:20 AM IST
      Bristol-Myers Squibb Co said it would license two of its drugs to Biogen Inc and Roche Holding AG for an upfront fee of $470 million.Bristol will...
      Apple hires secret team for treating diabetes: Report

      Apple hires secret team for treating diabetes: Report

      supriya kashyap kashyap13 April 2017 12:54 PM IST
      Apple Inc has hired a team of biomedical engineers as part of a secret initiative, initially envisioned by late Apple co-founder Steve Jobs, to...
      Strand Life Sciences launches Liquid Biopsy test tool

      Strand Life Sciences launches Liquid Biopsy test tool

      supriya kashyap kashyap13 April 2017 12:54 PM IST
      Bengaluru : Developing a health product that can help with better detection of cancer, city-based Strand Life Sciences launched 'Strand LB' a Luquid...
      Chinese private hospital to buy largest EU eye clinic group

      Chinese private hospital to buy largest EU eye clinic group

      supriya kashyap kashyap13 April 2017 12:52 PM IST
      Beijing : China’s largest private ophthalmic medical chain Aier Eye Hospital has said it will buy Europe’s biggest eye clinic group for over USD 160...
      Sanofi appoints N Kalra to lead consumer healthcare business

      Sanofi appoints N Kalra to lead consumer healthcare business

      supriya kashyap kashyap13 April 2017 12:52 PM IST
      Mumbai : Global healthcare firm Sanofi announced appointment of Nikhilesh Kalra as general manager of its consumer healthcare (CHC) business in India...
      Shilpa Medicare gets EIR from USFDA for Raichur facilities

      Shilpa Medicare gets EIR from USFDA for Raichur facilities

      supriya kashyap kashyap13 April 2017 12:51 PM IST
      New Delhi : Shilpa Medicare said the US health regulator has issued an Establishment Inspection Report (EIR) for its manufacturing facilities located...
      Toyota launches robotic leg brace to help paralyzed people walk

      Toyota launches robotic leg brace to help paralyzed people walk

      supriya kashyap kashyap13 April 2017 9:55 AM IST
      Tokyo : Toyota is introducing a wearable robotic leg brace designed to help partially paralyzed people walk.The Welwalk WW-1000 system is made up of a...
      OncoMed sinks as cancer drug fails; Bayer opts against licensing drugs

      OncoMed sinks as cancer drug fails; Bayer opts against licensing drugs

      supriya kashyap kashyap12 April 2017 12:13 PM IST
      OncoMed Pharmaceuticals Inc said it would discontinue a trial testing experimental stem cell therapy demcizumab as an initial treatment for advanced...
      Taking steps to discourage import of bulk drugs: Government

      Taking steps to discourage import of bulk drugs: Government

      supriya kashyap kashyap12 April 2017 12:10 PM IST
      New Delhi : Government is taking various policy initiatives, including withdrawal of customs duty exemption, to discourage import of bulk drugs and...
      FDA warns Mylan over quality concerns at India facility

      FDA warns Mylan over quality concerns at India facility

      supriya kashyap kashyap12 April 2017 12:10 PM IST
      The U.S. Food and Drug Administration (FDA) has raised concerns over quality controls at a Mylan NV manufacturing plant in India, according to a...
      FDA approves first drug to treat tardive dyskinesia

      FDA approves first drug to treat tardive dyskinesia

      supriya kashyap kashyap12 April 2017 12:09 PM IST
      The U.S. Food and Drug Administration approved Ingrezza (valbenazine) capsules to treat adults with tardive dyskinesia. This is the first drug...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok